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Abstract
Objective: The aim of the study was to determine the main factors (socio-
demographic, anthropometric, lifestyle and health status) associated with high Na
excretion in a representative population of Chile.
Design: Na excretion (g/d), a valid marker of Na intake, was determined by urine
analysis and Tanaka’s formulas. Blood pressure was measured by trained staff and
derived from the mean of three readings recorded after 15 min rest. The
associations of Na excretion with blood pressure and the primary correlates of
high Na excretion were determined using logistic regression.
Setting: Chileans aged ≥15 years.
Participants: Participants (n 2913) from the Chilean National Health Survey 2009–
2010.
Results: Individuals aged 25 years or over, those who were obese and those who
had hypertension, diabetes or metabolic syndrome were more likely to have
higher Na excretion. The odds for hypertension increased by 10·2% per 0·4 g/d
increment in Na excretion (OR= 1·10; 95% CI 1·06, 1·14; P < 0·0001). These
findings were independent of major confounding factors.
Conclusions: Age, sex, adiposity, sitting behaviours and existing co-morbidities
such as diabetes were associated with higher Na excretion levels in the Chilean
population. These findings could help policy makers to implement public health
strategies tailored towards individuals who are more likely to consume high levels
of dietary salt.
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Dietary Na is an important micronutrient required for a
variety of essential physiological functions within the
human body. However, there is convincing evidence
that high Na excretion (as a consequence of high Na
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intake) plays a role in endothelial dysfunction, ven-
tricular hypertrophy, and has deleterious effects on
blood pressure (BP), resulting in an increased hyper-
tension risk(1–4).
Hypertension, a multifactorial disease associated with
modifiable and non-modifiable risk factors(5,6), is the most
important risk factor for premature mortality worldwide
and a major risk factor for CVD and kidney disease(1,3,7–10).
More than one in five adults worldwide have high BP, and
it has been estimated that each year 9·4 million deaths
worldwide are caused by complications related to hyper-
tension(11). Lifestyle changes such as reducing dietary Na
intake are key to preventing and reducing the prevalence
of hypertension(10). The WHO currently recommends an
intake of less than 5 g salt/d (equivalent to < 2 g Na/d) in
the normotensive population and an intake of less than
1·5 g Na/d in individuals with hypertension(8,11). However,
the average consumption is 4·0 g Na/d (equivalent to 10 g
salt/d) worldwide(10). Na intake, therefore, is a key
behaviour that can be modified to reduce the risk of high
BP(12).
Over the last three decades, Latin American countries,
including Chile, have experienced a rapid lifestyle
transition owing to their populations adopting a more
Westernised lifestyle, including an increasingly unheal-
thy diet and reductions in physical activity (PA)(13–16). In
fact, Chile has the highest prevalence of obesity in Latin
America. Seven out of ten adults are overweight or
obese(17) and consequently at high risk of hyperten-
sion(16). It is perhaps not surprising, therefore, that in the
last Chilean National Health Survey 2016–2017, 27·6% of
the population were found to have hypertension (2·6%
more than in 2010)(18), with an average Na excretion of
3·7 g/d (equivalent to 9·4 g salt/d)(18). As a result, Chile
has the third highest prevalence of hypertension in Latin
America(19).
Given the rapid lifestyle transition and current levels
of hypertension in Chile, identifying the main factors
associated with higher Na excretion could help to
develop and tailor more effective public health policies.
The aim of the present study, therefore, was to
determine the main factors (sociodemographic,
anthropometric, lifestyle and health status) associated
with high Na excretion in a representative population
of Chile.
Methods
Study design
The present study was an observational, cross-sectional
analysis assessing the association of Na excretion with
hypertension in Chilean adults. The present paper is
reported in adherence to the Strengthening the Reporting
of Observational Studies in Epidemiology (STROBE)
guidelines(20).
Study population
The present study was based on participants aged ≥15
years from the 2009–2010 Chilean National Health Survey
(CNHS 2009–2010). The CNHS 2009–2010 is a large,
nationally representative population-based study of bio-
logical and lifestyle risk factors, dietary status and health,
conducted every six years in Chile in both urban and rural
zones. One participant was randomly selected per
household, with pregnant individuals and individuals with
violent behaviour excluded, as described elsewhere(17).
Data were collected by trained staff in two visits where
individuals were administered questionnaires and
anthropometric and physiological measures, as well as
biological samples, were obtained. The response rate from
the eligible population to the CNHS 2009–2010 was 54%
(n 5412). Of these, only 2913 participants had Na excre-
tion measured and were therefore included in the
present study.
Anthropometric and metabolic measurements
Weight was measured by a digital scale (Tanita HD-313®)
and height with a height rod in their home, with partici-
pants not wearing shoes and in light clothing, through
standardized methods and by trained nurses or midwives,
as described elsewhere(17). BMI was calculated as weight/
height2 and classified using the WHO criteria (normal
weight: 18·5–24·9 kg/m2; overweight: 25·0–29·9 kg/m2;
obese: ≥30·0 kg/m2)(21). Underweight individuals were
not included as only forty-six participants were classified
with a BMI < 18·5 kg/m2. Central obesity was defined as
waist circumference > 88 cm for women and >102 cm for
men(17) and was measured at the mid-axillary line at the
midpoint between the costal margin and the iliac crest by
an ergonomic circumference-measuring tape.
BP was measured using the Omron HEM 742® BP
monitor and cuff by trained staff and derived from the
mean of three readings recorded after 15 min of rest. Mean
arterial pressure was derived as: [(diastolic BP) × 2 +
systolic BP]/3. Hypertension was defined as systolic BP ≥
140mmHg (SBP) and diastolic BP ≥ 90mmHg (DBP) or
currently receiving treatment for hypertension(22). These
categories were established according to the Seventh
Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High BP(23).
Medication for lowering BP was collected using self-
reported questionnaires (694 participants were on medi-
cation). Type 2 diabetes was defined as fasting glucose ≥
7·0mmol/l or current treatment for diabetes(24). The pre-
sence of metabolic syndrome was defined using the
National Cholesterol Education Program Adult Treatment
Panel III criteria(25): waist circumference > 102 for men
and >88 cm for women; serum TAG > 1·7mmol/l; HDL-
cholesterol < 1·03mmol/l; SBP ≥ 130mmHg or DBP ≥
85 mmHg; and fasting glucose > 5·6mmol/l or current
treatment for diabetes. Each metabolic syndrome
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component was classified as either present or absent as
per the above criteria. The number of metabolic syndrome
components present for each participant was calculated to
provide an ordinal measure of cardiometabolic health. The
presence of three or more components was used to indi-
cate the presence of metabolic syndrome.
Sociodemographic characteristics
Sociodemographic data were collected for all participants,
including age, sex, education level (primary, < 8 years;
secondary, <12 years; beyond secondary, >12 years),
monthly household income (low, ≤ $US 480; middle, $US
481–865; high, ≥$US 865) and smoking status (non-smo-
ker, ex-smoker, smoker), using nationally validated
questionnaires. Dietary intake of fruit and vegetables was
reported using an FFQ which was administered once.
Participants were asked, ‘In a typical/ordinary week, how
many days do you eat fruit?’ and ‘In a typical/ordinary
week, how many days do you eat vegetables?’, which was
then converted into grams(17). Alcohol consumption was
self-reported and collected using the Alcohol Use Dis-
orders Identification Test (AUDIT) questionnaire devel-
oped by WHO(26) and adapted for use in Chile(27).
Sodium excretion
Daily Na excretion was determined using a urine sample
collected by trained nurses using a standardised protocol.
The indirect ion-selective method was utilised to measure
Na electrolyte in the urine (indirect potentiometry).
Although measurement of urinary Na excretion over 24 h
is the gold standard for assessing Na excretion in popu-
lation surveys, it is time-consuming and has a high burden
for participants and is therefore not always possible. In this
context, to calculate 24 h urinary Na excretion (24HUNa),
conversion formulas by Tanaka et al. were used. Tanaka’s
formulas require the measurement of Na and creatinine in
a spot urine sample as well as the age in years, body
weight in kilograms and height in centimetres for each
individual. This method is simple and has been previously
validated(28). The formulas are as follows:
PRCr mg=dð Þ=
204 ´ age yearsÞð + 1489 ´ body weight kgð Þ
+ 1614 ´ height cmð Þ224445; ð1Þ
Estimated 24HUNa meq=dð Þ= 2198´XNa0392; (2)
XNa= f½SUNa=ðSUCr ´ 10Þ ´ PRCrg0392; (3)
where PRCr is predicted value of 24 h urinary creatinine,
SUNa is Na concentration in the spot voiding urine and
SUCr is creatinine concentration in the spot voiding urine.
Physical activity and sedentary behaviour
PA levels, including moderate and vigorous intensities and
transport-related PA, were determined using the Global
Physical Activity Questionnaire version 2 (QPAQ v2)(29).
PA was categorised into: inactive individuals (<600 MET-
min/week) and active individuals (≥600 MET-min/week)(30),
where MET is metabolic equivalent of task. Sedentary
behaviour was derived using the following question: ‘How
much time do you usually spend sitting or reclining on a
typical day?’(30).
Statistical analyses
Statistical analyses were performed using survey-weighted
values and the statistical software package Stata version
14. Descriptive characteristics are presented as adjusted
means with 95% CI for quantitative variables or as a
proportion for categorical variables. High Na excretion
was defined as an excretion ≥ 3·6 g/d, which corresponds
to the population median. To determine the main socio-
demographic, health and lifestyle correlates of Na excre-
tion, we used logistic regression analysis where Na
excretion was the outcome coded as a binary variable
(0= low, 1=high). The exposures were fitted into the
model as categorical variables. For continuous variables, we
derived tertiles to investigate the odds of being in the high
Na excretion group by low, middle or high level of the
exposure variable of interest (low= 0, middle=1, high = 2).
Associations between Na excretion and BP (mean arterial
pressure, SBP and DBP) were investigated using linear
regression analysis. Individuals taking BP medication (n
694) were excluded from this analysis. The association
between Na excretion and hypertension (no=0, yes=1)
was investigated using multivariate logistic regression ana-
lyses for the linear association and splines logistic regression
with four equally distributed knots (at the 20th, 40th, 60th
and 80th percentiles) for non-linear associations.
Results are presented as means and 95% CI, and as OR
with their respective 95% CI, for BP and hypertension
outcomes, respectively. Analyses were performed using
incremental models. Model 0 was unadjusted; Model 1 was
minimally adjusted (age, sex, area of residence (rural,
urban), city of residence, education level and BP treatment);
and Model 2 was fully adjusted (age, sex, area of residence,
city of residence, education level, BP treatment, smoking,
sedentary behaviour, total PA and BMI category). A P value
of <0·05 was considered significant in all analyses.
Results
The main characteristics of participants by Na excretion
category (<3·6 g/d and ≥3·6 g/d) are summarised in
Table 1. Individuals who had Na excretion ≥3·6 g/d
(equivalent to >9 g salt/d) were older (47·4 years), more
likely to be male, and had lower levels of education and
household income. Furthermore, those with high Na
excretion were also more likely to be obese and have
more metabolic complications such as diabetes and
metabolic syndrome (34·0, 11·9 and 39·3%, respectively;
Table 1). The characteristics of participants without data
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Table 1 Characteristics, by urinary sodium excretion, of Chileans aged ≥15 years (n 2913) from the Chilean
National Health Survey 2009–2010
< 3·6g/d
(n 939)
≥ 3·6 g/d
(n 1974)
Characteristic Mean or n SD or % Mean or n SD or %
Sociodemographic
Age (years), mean and SD 44·5 18·7 47·4 18·4
Age category, n and %
< 25 years 168 17·9 262 13·3
24–44 years 324 34·5 643 32·6
45–65 years 279 29·7 658 33·3
> 65 years 168 17·9 411 20·8
Sex, n and %
Female 608 64·8 1089 55·2
Male 331 35·2 885 44·8
Area of residence, n and %
Urban 843 89·8 1638 83·0
Rural 96 10·2 336 17·0
Education, n and %
Up to primary (<8 years) 198 21·1 569 29·0
Up to secondary (<12 years) 522 55·7 1059 54·0
Beyond secondary (>12 years) 217 23·2 335 17·0
Income tertile, n and %
Low 455 50·7 1109 58·1
Middle 301 33·5 613 32·1
High 142 15·8 187 9·8
Anthropometric
BMI (kg/m2), mean and SD 26·5 5·0 28·5 5·5
BMI category, n and %
Normal weight (18·5–24·9 kg/m2) 369 40·3 485 25·3
Overweight (25·0–29·9 kg/m2) 344 37·6 782 40·7
Obese (≥30·0 kg/m2) 202 22·1 654 34·0
WC (cm), mean and SD 87·7 12·3 93·4 12·9
Central obesity, n and %
No 656 69·9 1054 53·4
Yes 283 30·1 920 46·6
Lifestyle
Total PA (MET-h/week), mean and SD 105·6 136·6 129·1 15·9
Transport PA (min/d), mean and SD 49·8 86·7 49·0 85·2
Moderate PA (min/d), mean and SD 85·8 133·4 109·9 153·1
Vigorous PA (min/d), mean and SD 45·4 115·9 58·8 130·3
PA category, n and %
Active 680 74·5 1479 76·8
Inactive 233 25·5 448 23·2
Sitting time (h/d) 3·7 2·7 3·3 2·7
Fruit and vegetable intake (g/d), mean and SD 216·8 134·0 214·7 139·6
Na excretion (g/d), mean and SD 2·8 0·4 4·4 1·1
Alcohol intake (g/d), mean and SD 45·9 63·9 53·8 72·4
Smoking status, n and %
Never 351 37·5 850 43·2
Ex-smoker 217 23·1 473 24·1
Current smoker 369 39·4 643 32·7
Health status
Diabetes, n and %
No 840 92·0 1680 88·1
Yes 73 8·0 227 11·9
Metabolic syndrome, n and %
No 582 71·9 1019 60·7
Yes 227 28·1 661 39·3
Treatment for blood pressure, n and %
Medication only 75 8·0 202 10·2
Lifestyle only 23 2·4 40 2·0
Lifestyle and medication 33 3·5 72 3·7
None 808 86·1 1660 84·1
Family history of hypertension, n and %
No 555 60·7 1163 61·7
Yes 360 39·3 723 38·3
SBP (mmHg), mean and SD 123·3 21·0 130·8 23·3
DBP (mmHg), mean and SD 74·6 10·9 77·4 11·5
WC, waist circumference; PA, physical activity; MET, metabolic equivalent of task; SBP, systolic blood pressure; DBP, diastolic
blood pressure.
Data presented as mean and SD for continuous variables, or as n and % for categorical variables. Na excretion was determined
through a urine sample and then transformed into a 24 h Na excretion value using formulas by Tanaka et al.(28). Na excretion
<3·6g/d was used as a reference group.
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available for Na excretion are presented in the online
supplementary material, Table S1. However, no major
differences were observed between those with and with-
out data available for Na excretion.
There was a significant association between Na excre-
tion and systolic, diastolic and mean arterial BP as is
shown in the online supplementary material, Table S2 and
Fig. 1. Per 0·4 g increase in Na excretion, SBP increased by
2·06mmHg (95% CI 1·7, 2·4mmHg, P< 0·0001; Fig. 1(a)),
DBP increased by 0·85mmHg (95% CI 0·7, 1·0mmHg,
P< 0·0001; Fig. 1(b)) and mean arterial pressure increased
by 3·76mmHg (95% CI 3·1, 4·4mmHg, P<0·0001; Fig. 1(c)).
These associations were independent of major confounding
factors as demonstrated in Table S2.
The odds for hypertension increased by 10·2% per each
0·4 g increment of Na excretion (OR= 1·10; 95% CI 1·06,
1·14; P< 0·0001). When a non-linear association was
investigated, using splines regression with four knots
equally distributed (20th, 40th, 60th and 80th percentiles),
the results showed that the biggest increase in the odds for
hypertension was observed when Na excretion was above
8 g/d (OR= 1·21; 95% CI 1·01, 1·45; P< 0·0001; Fig. 2 and
online supplementary material, Table S3). These findings
were independent of age, sex, education level, BP-
lowering medication, smoking, sedentary behaviour,
total PA and BMI category (Fig. 2 and Table S3).
On the other hand, correlate analysis of high Na
excretion (≥3·6 g/d) showed that individuals aged over
25 years, those who were overweight, obese or centrally
obese, individuals who reported to be taking BP-lowering
medication and individuals with hypertension, diabetes
and metabolic syndrome were more likely to have a high
Na excretion (Fig. 3). Obesity and central obesity were the
strongest factors associated with high Na excretion
(OR= 2·50; 95% CI 2·01, 3·11; P< 0·0001 and OR= 2·26;
95% CI 1·88, 2·72; P< 0·0001, respectively). By contrast,
individuals living in an urban setting, females, those with
> 12 years of education, those in middle- or high-income
groups and those who spent more time sitting were less
likely to be in the higher Na excretion category (Fig. 3).
Discussion
The main findings of the present study are that males,
individuals who are older, individuals who are overweight
or obese, and those who have been diagnosed with
hypertension, metabolic syndrome or diabetes are more
likely to have higher Na excretion (≥3·6 g/d) within the
Chilean population. Conversely, females, individuals with
high levels of education or income, those living in urban
cities, those who are more physically active and also
people who reported spending more time sitting were less
likely to be in the high excretion group. A possible
explanation for these findings may be related to this
population being more aware of, and having increased
access to, health information(31). Additionally, the odds of
having hypertension increased by 10·2% per each 0·4 g
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Fig. 1 Asociation of sodium excretion with (a) systolic blood
pressure (SBP), (b) diastolic blood pressure (DBP) and (c)
mean arterial blood pressure (MAP) in Chileans aged ≥ 15
years (n 2913) from the Chilean National Health Survey 2009–
2010. Data are presented as means with their 95% CI
indicated by vertical bars; indicates the population
average blood pressure, indicates the population
average Na excretion. Analyses were adjusted age, sex, area
of residence (rural, urban), city of residence, education level,
smoking, sedentary behaviour, total physical activity and BMI
category. Participants who were on blood pressure-lowering
medication were removed from this analysis (n 694)
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increment in Na intake. These findings could be relevant
for informing national public health policy makers of the
need for strategies to decrease the current levels of Na
consumption in the population, which are currently
reported as 3·7 g/d(18). WHO is currently providing
support to governments in a bid to implement policies
aimed at reducing the global Na intake, with a target of a
30% reduction by 2025(10). However, if Na intake con-
tinues to increase in Chile, the country could be at an
increased risk of poor health and face a greater economic
burden from the many chronic health conditions asso-
ciated with high Na intake. In fact, Na intake was shown to
be the primary factor accounting for the rising hyperten-
sion prevalence in Chile, which has increased from 26·9%
in 2010 to 27·6% in 2017(17,18).
Despite the present study being the first to investigate
correlates of higher Na excretion in the Chilean popula-
tion, research conducted in different middle- and high-
income countries (China, Denmark, France, Slovenia,
Japan and the USA) has shown similar associations(32,33).
Indeed, previous studies have shown that those with
higher Na intakes were more likely to be older indivi-
duals(32,33), male(34), have a diagnosis of metabolic syn-
drome(35) and hypertension(35,36), and a high BMI(36–38).
In the last two decades, the effects of dietary Na on
human BP, predominantly through Na intake, have been
investigated in several epidemiological and interventional
studies(39,40). In Japan, a 2-year follow-up study of 6103
individuals showed that the risk of developing hyperten-
sion was higher in those with higher Na intake (hazard
ratio= 1·25; 95% CI 1·04, 1·50)(39). Mozaffarian et al., as
part of the Global Burden of Diseases Nutrition and
Chronic Diseases Expert Group (NUTRICODE), conducted
a meta-analysis on Na consumption worldwide and cal-
culated the dose–response relationship between Na and
BP(41). The data showed a linear dose–response relation-
ship between reduced Na intake and SBP, where a
decrease of 2·3 g Na/d was associated with a reduction in
BP of 3·82mmHg(41). Similarly, a meta-analysis of thirty-six
studies showed that a reduction of Na intake significantly
reduced SBP by 3·39mmHg and DBP by 1·54mmHg(42).
Mente et al. showed that the exclusion of individuals on
medication did not substantially alter the magnitude of the
association of 2·24mmHg increment in SBP per 0·4 g of
Na(43). Our findings are consistent with these results where
a 0·4 g increment in Na excretion was associated with 2·06
and 0·85mmHg higher SBP and DBP, respectively.
Although Chile has the third highest prevalence of
hypertension within Latin American countries, the present
study is the first to investigate the correlates of Na excre-
tion (a proxy of salt intake) and its association with
hypertension. This is particularly important because, even
if similar associations have been shown in other middle-
and high-income countries, such local data are needed to
inform the policies and public health interventions
implemented in Chile. Our non-linear association analysis
shows that hypertension risk increases significantly when
Na excretion reaches 3·2 g/d. This is clinically relevant as
more than 67% of the Chilean population consumes
≥9 g salt/d. If intake at this level continues, the prevalence
of hypertension, and consequently the burden of CVD, is
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Fig. 2 Association between sodium excretion and hypertension
in Chileans aged ≥15 years (n 2913) from the Chilean National
Health Survey 2009–2010. Data are presented as OR (———)
and their 95% CI ( ); denotes OR = 1. (a) Model 0,
unadjusted; (b) Model 1, adjusted for age, sex, area of residence
(rural, urban), city of residence, education level and blood pressure
treatment; (c) Model 2, adjusted for Model 1 plus smoking,
sedentary behaviour, total physical activity and BMI category
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Age category
< 25 years (Ref.)
25–44 years
45–65 years
> 65 years
Sex
Male (Ref.)
Female
Area of residence
Rural (Ref.)
Urban
Education
Up to primary (< 8 years) (Ref.) 1.00
Up to secondary (< 12 years)
Beyond secondary (> 12 years)
Income tertile
Low (Ref.)
Middle
High
BMI category
Normal (Ref.)
Overweight
Obese
Central obesity
No (Ref.)
Yes
Physical activity category
Active (Ref.)
Inactive
Sitting time
Low (< 4 h/d) (Ref.)
High (> 4 h/d)
Smoking status
Never (Ref.)
Ex-smoker
Smoker
Hypertension
No (Ref.)
Yes
Hypertension treatment
Lifestyle (Ref.)
Medication
Medication and lifestyle
None
Diabetes
No (Ref.)
Yes
Metabolic syndrome
No (Ref.)
Yes
OR 95 % CI P  value
1.00
1.29
1.53
1.61
1.00
0.66
1.00
0.57
0.71
0.55
1.00
0.82
0.52
1.00
1.66
2.50
1.00
2.26
1.00
0.85
1.00
0.75
1.00
0.82
0.71
1.00
1.56
1.00
1.21
0.84
1.01
1.00
1.39
1.00
1.53
1.21,
1.23,
0.56,
0.45,
0.57,
0.42,
0.69,
0.41,
1.37,
2.01,
1.88,
0.70,
0.64,
0.67,
0.59,
1.27,
1.03,
0.72,
0.71,
1.04,
1.26,
1.02, 1.63
1.93
2.11
0.78
0.72
0.88
0.72
0.97
0.66
2.01
3.11
2.72
1.03
0.88
1.00
0.85
1.92
1.42
0.98
1.43
1.86
1.86
0.034
< 0.0001
0.001
< 0.0001
< 0.0001
< 0.002
< 0.0001
0.024
< 0.0001
< 0.0001
< 0.0001
< 0.0001
0.101
< 0.0001
0.054
< 0.0001
< 0.0001
0.020
0.027
0.947
0.026
< 0 .0001
0.2 0.5 1 2 5
More likely to have a
lower Na excretion
More likely to have a
higher Na excretion
OR (95 % CI)
Fig. 3 Correlates of high sodium excretion in Chileans aged ≥15 years (n 2913) from the Chilean National Health Survey 2009–
2010. Data are presented as OR (■) with their 95% CI represented by horizontal bars. Low sodium excretion (<3·6 g/d) was used
as a reference category (Ref.), therefore OR above 1 indicates that individuals were more likely to have higher sodium intake.
Analyses were adjusted for age, sex, area of residence (rural, urban), city of residence, education level, smoking, sedentary
behaviour, total physical activity and BMI category, except when these variables were used as main exposures
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likely to increase significantly in the short to middle term.
In this context, new and effective strategies towards Na
intake and therefore BP reductions are needed. A clear
example of the effect of Na intake reduction on BP is the
findings identified by He et al. in a meta-analysis of thirty-
four trials (3230 participants) which suggested that redu-
cing Na intake from 3·6–4·8 g/d to 2·0–2·4 g/d would have
a major effect on BP, but a further reduction to 1·2 g/d
would have an even greater effect and should become the
long-term target for population(12).
Factors such as age, sex, BMI and metabolic syndrome
have been shown to be correlated with Na intake in pre-
vious studies(44). To our knowledge, the present study is
the first to investigate the relationship of the lifestyle fac-
tors, PA and sitting time, with Na excretion. Both physi-
cally active and sedentary individuals were less likely to
have a high-Na diet. This observation exposes potential
discrepancies in health behaviours. Further investigation
into the motivations for the low Na intake in these groups
is required because, if there is a health-conscious moti-
vation for this, exploring why individuals remain seden-
tary when making other healthy lifestyle decisions could
further inform public health policies and interventions.
Limitations of the study
The CNHS 2009–2010 is a nationally representative sample
of the adult Chilean population. Although these data were
collected several years ago, which may reduce their
influence in a country with a rapidly changing lifestyle/
obesity landscape, they are the most up-to-date informa-
tion available from Chile. Although the inclusion of a wide
range of health, demographic and behavioural variables in
the data set allowed for comprehensive adjustment for the
effect of confounding factors, the CNHS has limited data
available regarding other dietary behaviours such as fruit
and vegetable, processed meat and other food intakes,
which has limited our ability to take into account their
potential confounding effect in the current study. Another
limitation was the lack of data on energy expenditure or
energy intake to account for their potential modifying
effect on the associations described herein; however, we
have used the total PA as a proxy of energy expenditure to
account for some of these effects. Moreover, Na excretion
was derived from validated equations using a fasted urine
sample(28), which has been shown to be a better estimator
of Na excretion than self-reported questionnaires. Never-
theless, 24HUNa is still considered the gold standard
method for assessing Na excretion and consequently the
use of a spot urine sample may have impacted on
the validity of these results. Only seventy-two (2%) par-
ticipants met the WHO’s Na intake recommendation
(<2·0 g/d) in the current study, therefore the population
median was used to classified people as low and high Na
intake, which could influence some of the estimated OR.
On the other hand, as with all observational studies, our
findings cannot prove causality, although previous ran-
domised controlled trials have shown the causal effect of
Na excretion on BP and hypertension risk(12). In addition,
lifestyle exposures such as dietary intake and PA were self-
reported, which has been shown to be prone to bias
previously. This could obscure the true association
between lifestyle factors and Na intake, and therefore
future studies using objective measures for PA and better
methods for dietary intake assessment are required.
Another limitation that could cause self-selection bias is
differences between the response rate in the total popu-
lation and those who agreed to urine sampling. However,
the characteristics of those without urinary Na excretion
data were very similar to those with data available.
Conclusion
The present data have identified the main factors asso-
ciated with higher Na excretion in a nationally repre-
sentative population of Chile. The study has also
corroborated the association of Na excretion with BP and
hypertension, independent of major confounding factors.
Given that Chile has the third highest prevalence of
hypertension in Latin America, these findings can help
create urgent policies and public health interventions for
this at-risk population.
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